Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pfizer Animal Genetics Resource Report Resource Website 1000+ mentions |
Pfizer Animal Genetics (RRID:SCR_008447) | topical portal, data or information resource, portal | THIS RESOURCE IS NO LONGER IN SERVICE, documented on January 31, 2022. Data services to support validation of economically relevant traits for the livestock industries. Sponsors: This resource is supported by Pfizer Animal Health. Keywords: Animal, Genetics, Health, World, Genetic, Information, Service, Industry, Livestock, DNA, Maker, Technology, Phenotypic, Productivity, |
is related to: eTRIKS is related to: OncoTrack is related to: EU-AIMS is related to: Investigator Databank is related to: Kidney Health Initiative is related to: NEWMEDS is related to: ORBITO is related to: Patients to Trials Consortium is related to: Structural Genomics Consortium is related to: Asian Cancer Research Group is related to: Open PHACTS is related to: EMIF is parent organization of: Pistoia Alliance |
THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-30302 | SCR_008447 | Pfizer | 2026-08-01 12:03:53 | 1400 | |||||||||
|
Pistoia Alliance Resource Report Resource Website 1+ mentions |
Pistoia Alliance (RRID:SCR_010563) | nonprofit organization | Not for profit, precompetitive alliance of life science companies, vendors, publishers, and academic groups that aims to lower barriers to innovation by improving interoperability of R and D business processes. | has parent organization: Pfizer Animal Genetics | nlx_38664 | SCR_010563 | 2026-08-01 12:04:14 | 6 | |||||||||||
|
Structural Genomics Consortium Resource Report Resource Website 50+ mentions |
Structural Genomics Consortium (RRID:SCR_003890) | SGC | portal, consortium, data or information resource, organization portal | Charity registered in United Kingdom whose mission is to accelerate research in new areas of human biology and drug discovery.Not for profit, public-private partnership that carries out basic science of relevance to drug discovery whose core mandate is to determine 3D structures on large scale and cost effectively targeting human proteins of biomedical importance and proteins from human parasites that represent potential drug targets. | basic science, drug discovery, drug, structural genomics, genomics, 3d structure, protein, human parasite, drug target, structure, human protein, protocol, phylogenetic tree, histone tail, high-throughput protein crystallization, lex bubbling system, reagent, epigenetic probe, antibody, vector, plasmid, construct |
uses: Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB) uses: Addgene uses: GenBank is related to: AbbVie is related to: Canada Foundation for Innovation is related to: Canadian Institutes of Health Research is related to: Genome Canada is related to: Janssen Research and Development is related to: Ontario Ministry of Economic Development Employment and Infrastructure is related to: Pfizer Animal Genetics is related to: Wellcome Trust has parent organization: University of Oxford; Oxford; United Kingdom has parent organization: University of Toronto; Ontario; Canada |
Cancer, Diabetes, Obesity, Psychiatric disorder, Altzheimer | AbbVie ; Boehringer Ingelheim ; Canada Foundation for Innovation ; Canadian Institutes of Health Research ; Genome Canada ; GlaxoSmithKline ; Janssen ; Lilly Canada ; Novartis Research Foundation ; Ontario Ministry of Economic Development Employment and Infrastructure ; Pfizer ; Takeda ; Wellcome Trust |
Restricted | nlx_158220 | SCR_003890 | Structural Genomics Consortium | 2026-08-01 12:02:34 | 61 | |||||
|
ORBITO Resource Report Resource Website 1+ mentions |
ORBITO (RRID:SCR_003876) | ORBITO | portal, consortium, data or information resource, organization portal | Project that aims to increase understanding of how orally-administered drugs are taken up from the gastrointestinal tract into the body, and apply this knowledge to create new laboratory tests and computer models that will better predict the performance of these drugs in patients over a range of clinically relevant conditions. The integration of in vitro and in silico approaches will provide a biopharmaceutics toolkit, validated using clinical data, to accelerate drug development. Ultimately, the project will help to facilitate and speed up the formulation development process and significantly reduce the need for animal experiments in this area as well as for human clinical studies in the future. For patients, the main benefit will be in the form of high quality medicines where the dose required is well calculated and is released in a way that consistently provides an optimal clinical effect. | drug, drug development, tool development, computer model, drug absorption, oral drug, gastrointestinal tract, clinical, in vivo, in vitro, in silico, biopharmaceutics, dose, drug performance |
is listed by: Consortia-pedia is related to: AbbVie is related to: Janssen Research and Development is related to: Merck is related to: Orion is related to: Pfizer Animal Genetics is related to: Uppsala University; Uppsala; Sweden is related to: University of Copenhagen; Copenhagen; Denmark is related to: University of Greifswald; Mecklenburg-Vorpommern; Germany is related to: Goethe University Frankfurt am Main; Hessen; Germany is related to: Johannes Gutenberg University Mainz; Rhineland-Palatinate; Germany is related to: Catholic University of Leuven; Flemish Brabant; Belgium is related to: Medical Products Agency; Uppsala; Sweden is related to: University of Athens; Athens; Greece is related to: TNO is related to: University of Manchester; Manchester; United Kingdom is related to: University of Strathclyde; Glasgow; United Kingdom is related to: Simcyp is related to: Sirius Analytical is related to: Simulations Plus has parent organization: Uppsala University; Uppsala; Sweden |
Innovative Medicines Initiative ; EFPIA |
nlx_158204 | SCR_003876 | orbito - Innovative Tools for Oral Biopharmaceutics, Oral biopharmaceutics tools (ORBITO) | 2026-08-01 12:02:22 | 7 | |||||||
|
EMIF Resource Report Resource Website 10+ mentions |
EMIF (RRID:SCR_010495) | EMIF | portal, consortium, data or information resource, organization portal | A project that aims to improve access to human health data by developing a common information framework (EMIF-Platform) that allows for efficient re-use of existing health data, opening up new avenues of research for scientists. To ensure immediate applicability, the project includes two specific therapeutic research topics: the onset of Alzheimer's Disease (EMIF-AD) and metabolic complications of obesity (EMIF-Metabolics). The AD Topic aims to discover and validate biomarkers of AD onset in the preclinical and prodromal phase as well as for disease progression and identify high-risk individuals for therapeutic trials for prevention. The Metabolic Topic aims to discover and evaluate biomarkers for the risk of metabolic complications in obesity and to identify high-risk populations for intervention purposes. Collaboration between the 3 topics will ensure the development and delivery of an efficient Information Framework. This initiative has combined several data sets for neuroimaging including ADNI and several others, curating them into transmart. | metabolic complication, biomarker, tool development, data sharing, health data, preclinical, prodromal, interoperability, adult human, pediatric, young human, cell model, animal model, therapeutic target, trial design, high-risk population, metabolic, health, platform, prevention, clinical trial, disease progression |
is related to: eTRIKS is related to: Roche is related to: Janssen Research and Development is related to: Pfizer Animal Genetics is related to: Brighton Collaboration is related to: Ealing Hospital; London; United Kingdom is related to: EuroRec is related to: European Molecular Biology Laboratory is related to: PENTA-ID is related to: University of Gothenburg; Gothenburg; Sweden is related to: University of Helsinki; Helsinki; Finland is related to: National Institute of Health and Medical Research; Rennes; France is related to: University of Eastern Finland; Eastern Finland; Finland is related to: Karolinska Institute; Stockholm; Sweden is related to: King's College London; London; United Kingdom is related to: Maastricht University; Maastricht; Netherlands is related to: Max-Planck-Gesellschaft is related to: University of Tartu; Tartu; Estonia is related to: VTT Technical Research Centre of Finland is related to: University of Aveiro; Aveiro; Portugal is related to: University of Pisa; Pisa; Italy is related to: University of Leipzig; Saxony; Germany is related to: Pompeu Fabra University; Barcelona; Spain is related to: University of Antwerp; Antwerp; Belgium is related to: University College London; London; United Kingdom is related to: University of Cambridge; Cambridge; United Kingdom is related to: University of Copenhagen; Copenhagen; Denmark is related to: University of Glasgow; Glasgow; United Kingdom is related to: University of Leicester; Leicester; United Kingdom is related to: University Hospital Erlangen; Bavaria; Germany is related to: University of Manchester; Manchester; United Kingdom is related to: Sorbonne University; Paris; France is related to: VIB; Flanders; Belgium is related to: Alzheimer Europe is related to: Cambridge Cognition is related to: concentris research management is related to: Custodix is related to: Genomedics is related to: PHARMO Institute is related to: Synapse Research Management Partners is related to: Proteome Sciences is related to: Pedianet is related to: Gnubila is related to: Medical Research Council is related to: Vestische Children and Youth Clinic Dates; North Rhine-Westphalia; Germany has parent organization: University of Oxford; Oxford; United Kingdom |
EFPIA ; Innovative Medicines Initiative 115372 |
nlx_158040 | SCR_010495 | European Medical Information Framework | 2026-08-01 12:03:52 | 45 | |||||||
|
Open PHACTS Resource Report Resource Website 10+ mentions |
Open PHACTS (RRID:SCR_005050) | OPS | consortium, data or information resource, portal, database, software resource, organization portal | Project that developed an open access discovery platform, called Open Pharmacological Space (OPS), via a semantic web approach, integrating pharmacological data from a variety of information resources and tools and services to question this integrated data to support pharmacological research. The project is based upon the assimilation of data already stored as triples, in the form subject-predicate-object. The software and data are available for download and local installation, under an open source and open access model. Tools and services are provided to query and visualize this data, and a sustainability plan will be in place, continuing the operation of the Open PHACTS Discovery Platform after the project funding ends. Throughout the project, a series of recommendations will be developed in conjunction with the community, building on open standards, to ensure wide applicability of the approaches used for integration of data. | drug, enzyme family, structure, receptor, target, ki, pathway, pharmacology, enzyme, small molecule, data mining, annotation, drug discovery, drug development, pharmacological profile, pharmacokinetic, admet data, biological target, chemical, linked data, rdf, nanopublication, platform, semantic technology, text mining, bioinformatics, cheminformatics, interoperability, chemistry, data provenance, compound, small molecule, semantic integration, drug discovery |
uses: CHEBI uses: ChemSpider uses: ConceptWiki uses: DrugBank uses: ENZYME uses: UniProt uses: Gene Ontology uses: WikiPathways is listed by: Consortia-pedia is listed by: FORCE11 is related to: Nanopub.org is related to: eTRIKS is related to: Janssen Research and Development is related to: Almirall is related to: ESTEVE is related to: Merck is related to: Pfizer Animal Genetics is related to: VU University; Amsterdam; Netherlands is related to: European Bioinformatics Institute is related to: Maastricht University; Maastricht; Netherlands is related to: University of Bonn; Bonn; Germany is related to: Royal Society of Chemistry is related to: Spanish National Cancer Research Center is related to: Netherlands Bioinformatics Centre is related to: SIB Swiss Institute of Bioinformatics is related to: Technical University of Denmark; Lyngby; Denmark is related to: University of Santiago de Compostela; Santiago de Compostela; Spain is related to: University of Vienna; Vienna; Austria is related to: University of Hamburg; Hamburg; Germany is related to: University of Manchester; Manchester; United Kingdom is related to: BioSolveIT is related to: ConnectedDiscovery is related to: OpenLink Software is related to: SciBite is related to: Open PHACTS Foundation has parent organization: University of Vienna; Vienna; Austria |
Innovative Medicines Initiative grant 115191; EFPIA ; Open PHACTS Foundation |
PMID:22683805 | Open unspecified license, Registration required, Non-commercial | r3d100011550, nlx_144033 | https://www.force11.org/node/4684, http://www.imi.europa.eu/content/open-phacts, https://doi.org/10.17616/R3T63F | SCR_005050 | Open PHACTS - Open Pharmacological Space, OpenPhacts.org, Open Pharmacological Space, Open Pharmacological Concepts Triple Store, OpenPHACTS, Open PHACTS: Open Pharmacological Space | 2026-08-01 12:02:53 | 11 | ||||
|
Patients to Trials Consortium Resource Report Resource Website |
Patients to Trials Consortium (RRID:SCR_003877) | Patients2Trials Consortium | consortium, data or information resource, portal, community building portal, service resource, organization portal, people resource | A three-member pharmaceutical industry consortium that aims to provide a new platform to improve access to information about clinical trials for patients and providers. The platform aims to enhance the existing clinicaltrials.gov by providing more detailed and patient-friendly information about available trials and embedding a machine-readable target health profile to improve the ability of healthcare software to match individual health profiles with applicable clinical trials. Using clinicaltrials.gov as its foundation and Eli Lilly''''s Application Programming Interface (API), the consortium is focused on creating an open platform to make this data more amenable to patients and providers, as well as creating an opportunity to integrate a patient''''s electronic health record into the clinical trial matching service. This feature will allow patients to search for trials using their own Blue Button data. The following features are planned add-ons to clinicaltrials.gov: * Target Profile is a machine readable query, that can be executed against an electronic file (or record) with patient health data such as an Electronic Health Record (EHR), an Electronic Medical Record (EMR) or Personally Controlled Health Record (PCHR) * Augmented Content is public, IRB approved information about the study that has not been published on clinicaltrials.gov, and that is shared with / targeted for patients with a matching Target Profile. The following are the incremental goals of the consortium: * Advancement of the Lilly API platform to support read/write interaction and additional data objects and information. * The initial 3 sponsor organizations - Lilly, Pfizer and Novartis - will upload Target Profiles for a select set of clinical trials. A Target Profile is a machine interpretable description of the characteristics of patients who may qualify for that trial i.e. a query that can be executed against a patient''''s electronic health record or personal health record. Additionally, sponsors of clinical research studies will also be able to upload Augmented Content to the Lilly Platform to supplement information on clinicaltrials.gov with additional, patient-focused information about the study, e.g., a study brochure and practical information on how to contact investigational sites. * A matching service, developed by Corengi, will compare Target Profiles to a de-dentified personally controlled health record (PCHR), represented by patient''''s Blue Button Plus CCDA XML document. * Integration into a patient community platform from Avado for providing the patient PCHR and presenting the results of the match service. The patient will be able to explore the respective matching studies for additional information and next steps such as contacting a nearby investigator clinic or hospital. The first demo of the prototype was made available on June 2014, built on a database of anonymized patient health records from different clinical research studies sponsored by Lilly, Novartis, and Pfizer. Other website: http://portal.lillycoi.com/ | drug development, tool development, clinical trial, clinical, patient profile, clinical research study, health record, platform, database |
uses: ClinicalTrials.gov is listed by: Consortia-pedia is related to: Pfizer Animal Genetics is related to: Corengi |
Open unspecified license, Public | nlx_158205 | SCR_003877 | p2t consortium | 2026-08-01 12:02:27 | 0 | |||||||
|
OncoTrack Resource Report Resource Website 1+ mentions |
OncoTrack (RRID:SCR_003767) | OncoTrack | portal, consortium, data or information resource, organization portal | An international consortium to develop and assess novel approaches to identify and characterize biological markers for colon cancer that will deepen the understanding of the variable make-up of tumors and how this affects the way patients respond to treatment. They will use cutting edge laboratory-based genome sequencing techniques coupled to novel computer modelling approaches to study both the biological heterogeneity of colon cancers (i.e. patient to patient variability) as well as tumor variation within the patient for example, by comparing primary tumors with metastases. This five year project brings together top scientists from European academic institutions offering a wide range of expertise, and partners them with pharmaceutical companies. The project is based on the premise that this genetic and epigenetic information, combined with a description of the molecular pathology of the tumor, will allow OncoTrack to generate a more accurate in-silico model of the cancer cell. This will facilitate the identification of predictive markers that can be used to guide the optimal therapy strategy at the level of the individual patient - and will also provide on-going prognostic guidance for the clinician. This project will not only advance understanding of the fundamental biology of colon cancers but will provide the means and approach for the identification of previously undetected biomarkers not only in the cancer under study, but potentially also in other solid cancers and, in doing so, open the door for personalized management of the oncology patient. | oncology, biomarker, diagnosis, basic science, genome sequencing, computer modelling, genetic, epigenetic, pathology, model, cancer cell, colon, cancer, treatment, genomics, clinical, systems biology, in-silico model, patient variability, tumor variability |
uses: GenomeWeb uses: eTRIKS is listed by: Consortia-pedia is related to: Roche is related to: Janssen Research and Development is related to: Merck is related to: Pfizer Animal Genetics is related to: Charite - Universitatsmedizin Berlin; Berlin; Germany is related to: Max Planck Institute for Molecular Genetics; Berlin; Germany is related to: Medical University of Graz; Graz; Austria is related to: Paris-Sud University; Paris; France is related to: Dresden University of Technology; Saxony; Germany is related to: University College London; London; United Kingdom is related to: Uppsala University; Uppsala; Sweden is related to: Stockholm University; Stockholm; Sweden is related to: Vall d'Hebron Institute of Oncology; Barcelona; Spain is related to: Alacris Theranostics is related to: Experimental Pharmacology and Oncology Berlin-Buch is related to: GABO:mi is related to: International Prevention Research Institute has parent organization: Max Planck Institute for Molecular Genetics; Berlin; Germany |
Innovative Medicines Initiative ; EFPIA |
nlx_158037 | SCR_003767 | OncoTrack - Methods for systematic next generation oncology biomarker development, Onco Track | 2026-08-01 12:02:25 | 9 | |||||||
|
eTRIKS Resource Report Resource Website 10+ mentions |
eTRIKS (RRID:SCR_003765) | eTRIKS | consortium, data or information resource, portal, service resource, organization portal | Research informatics and analytics platform for the IMI OncoTrack consortium. | data sharing, drug discovery, translational research, informatics, knowledge management, metadata standard, platform, analytics, tool development, bio.tools |
uses: tranSMART is used by: U-BIOPRED is used by: Predict-TB is used by: OncoTrack is used by: ABIRISK is used by: RA MAP is listed by: Consortia-pedia is listed by: Debian is listed by: bio.tools is related to: Roche is related to: Janssen Research and Development is related to: Merck is related to: Pfizer Animal Genetics is related to: Imperial College London; London; United Kingdom is related to: French National Center for Scientific Research is related to: Clinical Data Interchange Standards Consortium is related to: University of Luxembourg; Luxembourg; Luxembourg is related to: IDBS is related to: BioSci Consulting is related to: TraIT is related to: EMIF is related to: Open PHACTS has parent organization: Imperial College London; London; United Kingdom |
Innovative Medicines Initiative ; EFPIA |
PMID:29482119 | biotools:eTRIKS, nlx_158034 | https://bio.tools/eTRIKS | SCR_003765 | European Translational Information and Knowledge Management Services, European Translational Information & Knowledge Management Services | 2026-08-01 12:02:33 | 10 | |||||
|
NEWMEDS Resource Report Resource Website 1+ mentions |
NEWMEDS (RRID:SCR_003872) | NEWMEDS | portal, consortium, data or information resource, organization portal | Consortium that will develop new models and methods to enable novel treatments for schizophrenia and depression including three important missing tools that will facilitate the translation of scientific findings into benefits for patients. The project will focus on developing new animal models which use brain recording and behavioral tests to identify innovative and effective drugs for schizophrenia. The project will develop standardized paradigms, acquisition and analysis techniques to apply brain imaging, especially fMRI and PET imaging to drug development. It will examine how new genetic findings (duplication and deletion or changes in genes) influence the response to various drugs and whether this information can be used to choose the right drug for the right patient. And finally, it will try and develop new approaches for shorter and more efficient trials of new medication - trials that may require fewer patients and give faster results. | drug, biomarker, neuroimaging, drug development, tool development, animal model, fmri, pet, gene, medicine, clinical trial, genetic variation, molecule, model, dna, protein |
is listed by: Consortia-pedia is related to: Abbott Diagnostics is related to: Janssen Research and Development is related to: Orion is related to: Pfizer Animal Genetics is related to: Roche is related to: King's College London; London; United Kingdom is related to: Karolinska Institute; Stockholm; Sweden is related to: University of Cambridge; Cambridge; United Kingdom is related to: Central Institute of Mental Health; Mannheim; Germany is related to: Spanish National Research Council; Madrid; Spain is related to: University of Manchester; Manchester; United Kingdom is related to: Bar-Ilan University; Ramat Gan; Isreal is related to: Psynova Neurotech is related to: deCODE genetics is related to: GABO:mi is related to: AbbVie has parent organization: King's College London; London; United Kingdom is parent organization of: DepressionTools.org Clinical Significance Calculator is parent organization of: Pharmacological Imaging and Pattern Recognition toolbox is parent organization of: DUPCheck |
Innovative Medicines Initiative 115008; EFPIA |
nlx_158196 | SCR_003872 | Novel Methods leading to New Medications in Depression and Schizophrenia, NEWMEDS - Novel Methods leading to New Medications in Depression and Schizophrenia | 2026-08-01 12:02:34 | 6 | |||||||
|
Investigator Databank Resource Report Resource Website |
Investigator Databank (RRID:SCR_003866) | CPID | consortium, data or information resource, portal, community building portal, organization portal | Consortium between several pharmaceutical companies to develop a database that shares clinical trial investigator information that each company has on file to reduce administrative burden for investigators and to increase visibility of qualified investigators to research sponsors. Hosted by a 3rd party, DrugDev, it is the one place where pharmaceutical companies can share investigator and site information and investigators can view, edit, and comment on their own information. Industry members will be able share information from their clinical trial management systems including investigator / site contact details, GCP training records, past trial participation, and recruitment history. Upon investigator opt-in, this information is used by each participating company to identify sites for upcoming studies; to help set recruitment targets and timelines; and to share start-up documents such as CV, GCP, and site profile forms. The Databank has grown to include nearly 180,000 investigators (May 2014) and is already bringing benefits to its member companies in identifying qualified investigators for their studies. It also reported the inclusion of 7,335 protocols and 50K sites, representing a patient population around 1.9M. | drug development, clinical trial, pharmaceutical, investigator, sponsor, data sharing, protocol, drug, tool development, database, people resource |
uses: DrugDev is listed by: Consortia-pedia is related to: Janssen Research and Development is related to: Merck is related to: Pfizer Animal Genetics is related to: DrugDev has parent organization: Janssen Research and Development has parent organization: DrugDev |
The community can contribute to this resource | nlx_158192 | SCR_003866 | Cross-Pharmaceutical Investigator Databank | 2026-08-01 12:02:22 | 0 | |||||||
|
Kidney Health Initiative Resource Report Resource Website |
Kidney Health Initiative (RRID:SCR_003869) | KHI | portal, consortium, data or information resource, organization portal | Consortium that brings together the kidney community (patient advocacy groups, industry, government agencies, and professional organizations) to overcome existing challenges, including regulatory and nonregulatory barriers, and optimize the development and safety of products that impact kidney health including drugs, devices, biologics, and food products. The goals of the consortium are to: * Facilitate dialogue and research that informs regulatory processes with regard to the kidney health of patients being treated for kidney-related as well as other diseases. * Assess current medical therapies and diagnostics to identify areas in need of greater innovation and/or better defined regulatory pathways. * Develop innovative and efficient trial designs appropriate to answer the most important questions related to kidney health. * Establish expert consensus around common terminology and key definitions related to kidney health. * Develop approaches to the systematic collection of retrospective or prospective data, such as registries and/or global databases, and establishment of data standards. * Coordinate think tanks, public forums, educational exchanges, and other events to promote discussion and updates on topics in kidney health pertaining to drug, device, biologics, and food product development and evaluation. * Create transparent infrastructure and processes that facilitate collaboration and communication among the greater nephrology community and the FDA, including: * Seek input from all stakeholders (including nephrologists and other health professionals, patient groups, industry, the National Institutes of Health, the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, and other federal agencies). * Leverage previously conducted and ongoing clinical studies, research infrastructure, and databases. * Create an open and efficient mechanism for encouraging and objectively evaluating potential projects submitted to KHI. * Involve consortium members in the selection and execution of projects. * Establish systems to optimize post-market surveillance of products that affect kidney health, either intentionally or via adverse drug reactions. * Author journal articles and white papers regarding key issues, describing opportunities and challenges and proposing solutions, as well as promoting execution of these solutions. | device development, drug development, tool development, basic research, drug, device, biologics, food product, kidney, data standard, nephrology, safety, innovation, public health |
is listed by: Consortia-pedia is related to: AbbVie is related to: American Association of Kidney Patients is related to: American College of Clinical Pharmacy is related to: American Nephrology Nurses Association is related to: American Society for Apheresis is related to: American Society of Diagnostic and Interventional Nephrology is related to: ASN - American Society of Nephrology is related to: American Society of Pediatric Nephrology is related to: American Society of Transplantation is related to: Anthera Pharmaceuticals is related to: Arbor Research Collaborative for Health is related to: Association for the Advancement of Medical Instrumentation is related to: Baxter is related to: C. R. Bard is related to: ChemoCentryx is related to: ClinMet is related to: University of Oxford; Oxford; United Kingdom is related to: DaVita is related to: Dialysis Patient Citizens is related to: Duke University School of Medicine; North Carolina; USA is related to: ERA-EDTA is related to: FAST BioMedical is related to: Shire is related to: Home Dialyzors United is related to: Hospira is related to: All India Institute of Medical Sciences; New Delhi; India is related to: Juvenile Diabetes Research Foundation is related to: Karolinska Institute; Stockholm; Sweden is related to: University of Washington; Seattle; USA is related to: Mallinckrodt Pharmaceuticals is related to: MediBeacon is related to: Medtronic is related to: National Kidney Foundation is related to: National Renal Administrators Association is related to: NephCure Kidney International is related to: Nephrology Nursing Certification Commission is related to: Nephropath is related to: NxStage Medical is related to: OPKO is related to: Otsuka America Pharmaceutical Inc. is related to: Pfizer Animal Genetics is related to: PKD Foundation is related to: Proteon Therapeutics is related to: Puracath Medical is related to: Quintiles is related to: Reata Pharmaceuticals is related to: Relypsa is related to: Renal Physicians Association is related to: Renal Support Network is related to: Rockwell Medical is related to: St. Marianna University School of Medicine; Kawasaki; Japan is related to: Binding Site is related to: George Institute for Global Health is related to: Thrasos Therapeutics is related to: Vascular Access Society is related to: Vascular Access Society of the Americas is related to: Vascular Therapies is related to: Vasculitis Foundation is related to: W. L. Gore and Associates is related to: U.S. Food and Drug Administration has parent organization: ASN - American Society of Nephrology has parent organization: U.S. Food and Drug Administration has parent organization: Agency for Healthcare Research and Quality has parent organization: Centers for Medicare and Medicaid Services has parent organization: National Institutes of Health |
U.S. Food and Drug Administration ; Membership dues |
nlx_158194 | SCR_003869 | Kidney Health Initiative (KHI) | 2026-08-01 12:02:34 | 0 | |||||||
|
EU-AIMS Resource Report Resource Website 1+ mentions |
EU-AIMS (RRID:SCR_003861) | EU-AIMS | portal, consortium, data or information resource, organization portal | Consortium aiming to generate tools that will enhance understanding of autism spectrum disorders (ASD) and pave the way for the development of new, safe and effective treatments for use in both children and adults. For example, the team will gather samples from people bearing certain mutations associated with ASD; this will pave the way for the generation of cell lines that can be used to test treatments. Elsewhere, the researchers will advance the use of brain scans as a tool to boost ASD drug discovery and also identify which people with ASD might respond best to a given drug. The project will also create a pan-European network of clinical sites. As well as making it easier to run clinical trials, this network will create an interactive platform for those with ASD and professionals. By the end of the 5 year project they expect to provide novel validated cellular assays, animal models, new fMRI methods with dedicated analysis techniques, new PET radioligands, as well as new genetic and proteomic biomarkers for patient-segmentation or individual response prediction. They will provide a research network that can rapidly test new treatments in man. These tools should provide their EFPIA partners with an added competitive advantage in developing new drugs for ASD. | basic science, tool development, child, adult human, young human, treatment, diagnose, symptom, clinical, cell line, drug, drug discovery, neuroimaging, mutation, clinical trial, medicine |
is listed by: Consortia-pedia is related to: Roche is related to: Janssen Research and Development is related to: Pfizer Animal Genetics is related to: King's College London; London; United Kingdom is related to: Birkbeck University of London; London; United Kingdom is related to: Central Institute of Mental Health; Mannheim; Germany is related to: CEA; Gif sur Yvette; France is related to: European Molecular Biology Laboratory is related to: University College London; London; United Kingdom is related to: Pasteur Institute is related to: Karolinska Institute; Stockholm; Sweden is related to: Max-Planck-Gesellschaft is related to: Biomedical University Campus of Rome; Rome; Italy is related to: University of Basel; Basel; Switzerland is related to: Ulm University; Baden-Wurttemberg; Germany is related to: University of Cambridge; Cambridge; United Kingdom is related to: Autism Speaks is related to: GABO:mi is related to: deCODE genetics is related to: Noldus has parent organization: Roche |
Innovative Medicines Initiative ; EFPIA |
nlx_158184 | SCR_003861 | European Autism Interventions - A Multicentre Study for Developing New Medications, European Autism Interventions | 2026-08-01 12:02:22 | 2 | |||||||
|
Asian Cancer Research Group Resource Report Resource Website 1+ mentions |
Asian Cancer Research Group (RRID:SCR_004001) | ACRG | consortium, data or information resource, portal, data set, organization portal | An independent, not-for-profit consortium to accelerate research, and improve treatment for patients affected with the most commonly-diagnosed cancers in Asia by generating a genomic data resource for the most prevalent cancers in Asia. ACRG is focusing its initial efforts on Asian liver, gastric and lung cancers. Goals * Generate comprehensive genomics data sets for Asia-prevalent cancers * Conduct all research under good clinical practices and in accordance with local laws * Uncover key mutations and pathways for developing targeted therapies * Discover molecular tumor classifiers for patient stratification * Discover prognostic markers to identify high-risk patients * Freely share resulting raw data with scientific community to empower researchers globally and enable development of new diagnostics and medicines * Publish data analysis results jointly in prominent scientific journals Over the next two years, Lilly, Merck and Pfizer have committed to create an extensive pharmacogenomic cancer database that will be composed of data from approximately 2,000 tissue samples from patients with lung and gastric cancer that will be made publicly available to researchers and, over time, further populated with clinical data from a longitudinal analysis of patients. Comparison of the contrasting genomic signatures of these cancers could inform new approaches to treatment. Lilly has assumed responsibility for ultimately providing the data to the research public through an open-source concept managed by Lilly''''s Singapore research site. Moreover, Lilly, Merck and Pfizer will each provide technical and intellectual expertise. One dataset can be found at http://gigadb.org/dataset/100034 | asia, genomics, drug discovery, liver, gastric, lung, database, whole genome-wide study, drug development, basic research, data sharing, drug, oncology, pharmacogenomic, tissue, clinical, longitudinal |
uses: Gene Expression Omnibus uses: GigaDB is listed by: Consortia-pedia is related to: Merck is related to: Pfizer Animal Genetics is related to: BGI; Shenzhen; China has parent organization: Merck |
Eli Lilly and Company ; Merck ; Pfizer |
nlx_158412 | SCR_004001 | 2026-08-01 12:07:33 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
